期刊文献+

左炔诺孕酮纳米载药缓释复合材料对人精子活力及超微结构的影响 被引量:2

Effects of sustained-released levonorgestrel nanoparticle composites on human sperm motility and ultrastructure
原文传递
导出
摘要 目的:研究左炔诺孕酮纳米载药聚乳酸(PLA)-聚苯乙烯(PS)复合材料对人精子活力及超微结构影响。方法正常生育男性精液,经密度梯度离心处理后分为空膜组、载药膜组和正常对照组,分别与PLA-PS复合生物膜(空膜)、左炔诺孕酮纳米载药PLA-PS复合生物膜(载药膜)共培养24h,以未加膜培养的精子作为对照,计算机辅助精液分析(CASA)检测精子活力,透射电镜下观察各组精子超微结构的变化。结果(1)共培养24h后各组间精子活力差异无明显统计学意义(P>0.05);(2)空膜组精子的超微结构与对照组无明显差别;(3)载药膜组精子的顶体波浪状改变,顶体缺损或消失,质膜溶解,线粒体空泡样变,凋亡精子及崩解精子与空膜组及对照组比较明显增加。结论 PLA-PS复合材料本身对人精子活力及超微结构无明显影响,加入左炔诺孕酮纳米载药的PLA-PS复合材料可使精子超微结构改变,促进精子凋亡,为左炔诺孕酮纳米载药PLA-PS复合材料作为一种安全有效的新型生物可降解纳米载药宫内节育系统提供了进一步的实验依据。 Objective To investigate the effects of levonorgestrel-loaded nanoparticle composites on human sperm motility and ultrastructure. Methods Semen samples from normal reproductive males were collected anddivided into empty biofilm (polylactic acid-polystyrene composite biofilm) group, drug-loaded biofilm(levonorgestrel-loaded nanoparticle polylactic acid-polystyrene composite biofilm) group and normal control group. After co-culture with empty biofilm or drug-loaded biofilm for 24 hours, sperm motilityand sperm ultrastructure were detected by CASA and transmission electron microscope respectively. Results (1) No significant differences were observed in sperm motility among groups. (2) Compared with that of the control group, no obvious difference in sperm ultrastructure was found in empty biofilm group. (3) Remarkable differences were observed in drug-loaded biofilmgroup such as wavy change, defect or disappearance of acrosome, plasma membrane dissolved, vacuolar degeneration of mitochondria, as well as a significant increase in sperm apoptosis and disintegration of sperm. Conclusion Polylactic acid - polystyrene composites itself has no effects on human sperm motility and ultrastructure, levonorgestrel-loaded nanoparticle polylactic acid-polystyrene composites has obvious effect on human sperm acrosome, plasma membrane, mitochondria and promotes sperm apoptosis, which provides the theoretical basis for further study of biodegradable sustained-released nanoparticle drug-loaded intrauterine contraceptive system.
出处 《中国男科学杂志》 CAS CSCD 北大核心 2014年第5期7-10,共4页 Chinese Journal of Andrology
基金 国家自然科学基金青年基金项目(81100421) 江苏省科技支撑计划.社会发展项目(BE2010698)
关键词 纳米医学 左炔诺孕酮 精子 避孕 nanomedicine levonorgestrel spermatozoa contraception
  • 相关文献

参考文献9

二级参考文献21

  • 1盛志坚,侯春林.几丁糖影响体外细胞生长的实验研究[J].中国修复重建外科杂志,1993,7(4):244-245. 被引量:65
  • 2Zhu P,Contraception,1989年,40卷,425页
  • 3Vamshi K G,Franco M C. Interactions of carbon nanotube with lipid bilayer membranes[J].Journal of Nanomaterials,2011,(1155):830-836.
  • 4Zhen X U,Liu X W,Ma Y S. Interaction of nano-TiO2 with lysozyme:insights into the enzyme toxicity of nanosized particles[J].Environmental Science and Pollution Research,2010.798-806.
  • 5Manish S,Wing-cheung L,Wil iam A F. Employing materials assembly to elucidate surface interactions of amino acids with Au nanoparticles[J].KnechtSoft Mat er,2011.6532-6541.
  • 6LI W R,Xie X B,Shi Q S. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli[J].Applied Microbiology and Biotechnology,2010,(04):1115-1122.
  • 7孙康宁;李爱民.碳纳米管复合材料[M]北京:机械工业出版社,20101-16286-296.
  • 8杨详良;徐辉碧;廖明阳.纳米药物安全性[M]北京:科学出版社,20106.
  • 9余文娟,王向晖,史芹,黄蕊.纳米银对体外培养细胞附着形态及膜功能的影响[J].华东师范大学学报(自然科学版),2010(2):102-110. 被引量:7
  • 10吴嵩龄,杨大.Norplant皮下埋植避孕法对垂体和卵巢激素的影响[J].中国计划生育学杂志,1993,1(5):267-269. 被引量:3

共引文献119

同被引文献21

  • 1Sheng J, Zhang WY, Zhang JP, et al. The LNG - IUS study on adenomyosis: a 3 - year follow - up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis [ J ]. Contraception,2009, 79 (3): 189-193.
  • 2Loveless A, Dhari A, Kilpatrick CC. Perforated levonorgestrel - releasing intrauterine system resulting in small bowel obstruction: a case report [J]. J Reprod Med, 2014, 59 (11/12): 611-613.
  • 3Ji F, Yang XH, Ai Xing Zi AL, et al. Role of levonorgestrel - releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function [ J ]. Clin Exp Obstet Gynecol, 2014, 41 (6): 677-680.
  • 4Gemzell - Danielsson K, Inki P, Boubli L, et al. Bleeding pattern and safety of consecutive use of the levonorgestrel - releasing intrauterine system (LNG -IUS) a multicentre prospective study [J]. HumReprod, 2010, 25 (2): 354-359.
  • 5Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrel -releasing intrauterine device in patients with adenomyosis [ J J. Am J Obstet Gynecol, 2008, 198 (4): 3731-3317.
  • 6Lal S, Kriplani A, Kulshrestha V, et al. Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system [J]. Int J Gynaecol Obstet, 2010, 109 (2): 128 - 130.
  • 7Behnarnfar F, Ghahiri A, Tavakoli M. Levonorgestrel - releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia [ J ]. J Res Med Sci, 2014, 19 (8): 686-890.
  • 8刘凌宇,段华.左炔诺孕酮宫内缓释系统的临床应用不良反应与干预性研究[J].中国计划生育和妇产科,2014,6(1):35-38. 被引量:12
  • 9尚艳红,肖泽兵.曼月乐治疗子宫腺肌病100例临床研究[J].中国实用医刊,2014,41(5):69-71. 被引量:11
  • 10钟华,黄英.左炔诺孕酮宫内缓释系统治疗围绝经期功能失调性子宫出血的临床研究[J].中国实用医刊,2014,41(5):93-94. 被引量:14

引证文献2

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部